Biotech Values

[Bickema]

RVNC - I track Revance's decline all the way back to Dan Browne's comments about "not building a company to sell." I think the street learned that was the truth and not fluff, and has sold off RVNC's buy out vig to a valuation more appropriate wrt to time to market and necessary funding.

But fundamentally a very promising company.